Su Ran Mun

Title: Su Ran Mun: Innovator in Proteinopathy Treatment

Introduction

Su Ran Mun is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biomedical research, particularly in the treatment of misfolded protein diseases. With a total of 5 patents, her work focuses on innovative compounds and delivery systems that target proteinopathies.

Latest Patents

One of her latest patents is the "p62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same." This invention relates to a novel p62 ligand compound, which can be a stereoisomer, hydrate, solvate, or prodrug. The pharmaceutical or food composition derived from this compound is designed to prevent or treat misfolded protein diseases by activating selective autophagy in cells. This process helps in the selective elimination of proteins, organelles, and aggregates that contribute to various proteinopathies.

Another significant patent is the "cargo delivery system and composition comprising the same." This invention involves a cargo delivery system that includes an autophagy targeting ligand and a target-binding ligand. By utilizing this system, the cargo can be delivered to the p62 protein, activating autophagy and allowing for the selective removal of targets that need to be degraded. This system has potential applications in pharmaceutical and food compositions aimed at preventing and treating various diseases.

Career Highlights

Su Ran Mun has worked with notable organizations such as Autotac Inc. and Seoul National University. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to advancements in medical research.

Collaborations

Throughout her career, Su Ran Mun has collaborated with esteemed colleagues, including Yong Tae Kwon and Srinivasrao Ganipisetti. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Su Ran Mun is a trailblazer in the realm of proteinopathy treatment, with her innovative patents paving the way for new therapeutic approaches. Her work exemplifies the intersection of science and innovation, contributing to the advancement of medical solutions for complex diseases.